Status:
COMPLETED
Pancreatic Cancer Serum and DNA Repository
Lead Sponsor:
Pancreatic Cancer Research Team
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for earl...
Detailed Description
* To establish a central pancreatic cancer specimen repository to serve as a resource for current and future scientific studies. * To utilize the PCRT clinical data base to perform clinicopathologic c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
- Criteria
- Inclusion Criteria:
- 1 At the time of subject registration, CRAB will verify the institution's IRB date to ensure that the subject can be enrolled.
- 2 Potential study participants must meet the eligibility criteria found in Section 12.0 (Eligibility Checklist). Candidates will fall into one of four groups:
- Pancreatic cancer patients;
- Pancreatic and Liver Disease patients;
- Healthy, At-Risk Volunteers (smoker, (defined as individuals who have smoked \>= 100 cigarettes in their lifetime, and who currently smoke every day or some days \[MMWR November 12, 2004, 53(44);1035-1037\]), diabetic, and/or family history); and
- Healthy Volunteers (no history of cancer). The Eligibility Checklist must be photocopied, completed and stored on site. Eligibility is confirmed during registration, by answering yes to the question, Have all eligibility criteria been met? on the Registration Form.
- Eligibility Checklist:
- Pancreatic Cancer Patient Criteria All subjects, regardless of gender and ethnicity are eligible for this study Pathological diagnosis of pancreatic malignant neoplasm Expected availability of clinical follow up data Eighteen years old or older All subjects must be informed of the investigational nature of this protocol Written, informed consent obtained in accordance with institutional and federal guidelines
- Pancreatitis and Liver Disease Subject Criteria All subjects, regardless of gender and ethnicity are eligible for this study Pathological diagnosis of pancreatitis or liver disease Eighteen years old or older All subjects must be informed of the investigational nature of this protocol Written, informed consent obtained in accordance with institutional and federal guidelines
- Healthy, At-Risk Volunteers All subjects, regardless of gender and ethnicity are eligible for this study Is a smoker, is diabetic AND/OR has a family history of pancreatic cancer Eighteen years old or older with no history of cancer All subjects must be informed of the investigational nature of this protocol Written, informed consent obtained in accordance with institutional and federal guidelines
- Healthy Volunteers (no at-risk factors) All subjects, regardless of gender and ethnicity are eligible for this study Eighteen years old or older with no history of cancer All subjects must be informed of the investigational nature of this protocol Written, informed consent obtained in accordance with institutional and federal guidelines
Exclusion
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
690 Patients enrolled
Trial Details
Trial ID
NCT00296114
Start Date
February 1 2004
End Date
December 1 2011
Last Update
May 1 2013
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Scottsdale Healthcare
Scottsdale, Arizona, United States, 85259
2
University of Arizona/Arizona Cancer Center
Tucson, Arizona, United States, 85724
3
UCLA Medical Center
Los Angeles, California, United States, 90024-6970
4
RUSH University Medical Center
Chicago, Illinois, United States, 60612